Elan trumpets earning potential from court win

IN these troubled times Elan seems to have come up with a mice little earner.

The company has won a court victory supporting its right to charge the prestigious Mayo research foundation licence fees for its use of transgenetic mice developed and patented by Elan.

The ruling couldn’t have come at a better time, with Elan having been dogged by US accountancy woes which saw its shares drop sharply and left its shareholders really cheesed off.